MELOXICAM (MOVAL1S): THE SELECTIVE INHIBITOR OF COX-2 IN CLINICAL PRACTICE
Main Author: | V A Nassonova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2000-08-01
|
Series: | Научно-практическая ревматология |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/485 |
Similar Items
-
Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma
by: Yinghong Zhou, et al.
Published: (2020-01-01) -
Safe use of meloxicam in clinical practice
by: E. I. Sas, et al.
Published: (2019-03-01) -
Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2.
by: Haitao Li, et al.
Published: (2013-01-01) -
Performance Evaluation of Different Filter Media in Turbidity Re¬moval from Water by Application of Modified Qualitative Indices
by: G Badalians Gholikandi, et al.
Published: (2012-04-01) -
CEPHALOMETRIC SASSOUNI PLUS ANALYSIS USAGE FOR EVALUATING THE EFFECTIVENSS OF DISTAL BITE TREATMENT WITH AN ORTHODONTIC APPLIANCE WITH A MOVALE RAMP
by: P.S. Flis, et al.
Published: (2017-03-01)